State-owned energy company MVM has signed a five-year agreement to buy 2 billion cubic metres of LNG from Chevron, Minister ...
Hungarian energy company MVM plans geothermal exploration near Kiskunhalas with an investment of about HUF 8 billion, aiming to assess resources for future energy use.
Hungary's state-owned energy company, MVM, has entered into a five-year agreement with American energy giant Chevron for the supply of two billion cubic meters of liquefied natural gas (LNG). This ...
Hungary badly needs to secure more electricity. But despite recent deals in the Balkans, the country’s state energy company MVM has neither the nous nor the money to fulfil its regional dreams. In mid ...
Holtec International has announced a memorandum of understanding with Hungary's energy giant MVM to explore the deployment of ...
Hungary's state-owned MVM group has signed a 5-year deal with U.S. energy company Chevron for the supply of 2 billion cubic ...
Joe Biden once pledged to “undo the moral and national shame” of the Trump administration’s border policies—and even voiced remorse over some actions taken under President Barack Obama. But The Daily ...
Agreement initiates the design and development of hybrid dry–wet cooling towers, leveraging an existing, proven design platform to prioritize air-based cooling and dramatically reduce water use ...
Large federal contractor MVM Inc. is laying off 379 people who work in immigration-related jobs along the U.S.-Mexico border, including 247 workers in El Paso. The layoffs, to take effect Tuesday, ...
The office building where immigrant children were detained in June is on a main street just outside downtown Phoenix. Defense contractor MVM Inc., which leased the building in March, calls it a ...
Fermi America has signed a non-binding Memorandum of Understanding (MoU) with power-cooling firm MVM EGI Zrt. to develop cooling systems for its planned up to 11GW data center and energy campus in ...
AMSTERDAM--(BUSINESS WIRE)--Avanzanite Bioscience B.V. (Avanzanite), a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today announced a €32 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback